Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cytodyn Inc (OP: CYDY )

1.187 USD -0.090 (-7.05%)
Streaming Delayed Price Updated: 12:59 PM EST, Nov 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,984,751
Open 1.240
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.276
Today's Range 1.150 - 1.290
52wk Range 1.080 - 7.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CytoDyn Announces Preliminary Results from 2021 Annual Meeting
CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced... 
From Business Wire News Releases
Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH Trial Produces Fibrosis Reduction as High as 93 msec Amongst First 15 Patients with Average Reduction of 24 msec
CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today... 
From Business Wire News Releases

Performance

YTD
-80.13%
-80.13%
1 Month
-8.73%
-8.73%
3 Month
-7.30%
-7.30%
6 Month
-37.55%
-37.55%
1 Year
-55.39%
-55.39%

More News

Read More
CytoDyn Research Paper on Leronlimab Published in Frontiers in Immunology Journal
From Business Wire News Releases
Health Canada Authorizes Emergency Use of Leronlimab for Treatment of First Triple-Negative Breast Cancer Patient in Canada
From Business Wire News Releases
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to Lack of Quorum
From Business Wire News Releases
CytoDyn Announces Delaware Court Has Denied Activist Group’s Motion to Prevent Annual Meeting from Taking Place
From Business Wire News Releases
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting
From Business Wire News Releases
CEO Presenting on the Emerging Growth Conference on September 29 Register Now
From GlobeNewswire News Releases
Group of CytoDyn Stockholders Comments on Delaware Court Decision
From Business Wire News Releases
Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid
From Business Wire News Releases
CytoDyn Comments on Rosenbaum/Patterson Activist Group “Plan”
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.